Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care

Author(s):

Carmen Kosicek, MSN, PMHNP-BC,Deb York, MSN, PMHNP-BC, APRN, CCRA

Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.

Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care

EP: 1.Overview of PPD and Current Management Practices

EP: 2.New FDA-Approved Treatments for PPD

EP: 3.The Case of a 34-Year-Old Woman With PPD After the Birth of her Third Child

EP: 4.Diagnostic Tools for PPD

EP: 5.Treatment Choices For PPD and Peripartum Depression

EP: 6.Monitoring Treatment Response and Challenges in Managing PPD Patients in Ob/Gyn Practices

EP: 7.A Case of PPD in a Mother With a History of Major Depressive Disorder

EP: 8.Assessing Symptoms, Treatment Decision-Making, and Monitoring

EP: 9.Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care